Regulatory affairs has undergone significant transformation in 50 years.
Join RAPS in celebrating its 50th anniversary. Throughout the year, we’ll reflect on how our profession has evolved into a driving force for innovation—bridging healthcare products with the patients who rely on them.
Take part in celebrating this milestone and join the conversation shaping the next era of regulatory affairs.
Chris Whalley is shepherding the future of regulatory affairs as RAPS Convergence Planning Committee Chair and contributing to books like Regulatory Intelligence Reimagined. Chris has also served on the RAPS Convergence Planning Committee as a member and as vice chair, and currently leads regulatory intelligence activities at Pfizer as their senior director and head of global regulatory intelligence & analysis.
How has regulatory affairs changed in the last 50 years?
